Becton, Dickinson and Co. (BDX)

From the record

Becton, Dickinson and Co.'s filings since 2017 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

From the record

Becton, Dickinson and Co.'s 10 filed years say what it did: revenue went from $12 billion in fiscal 2016 to $22 billion in fiscal 2025, up 6.4% a year; it rose in 6 of 9 years; the deepest fall was 7% from fiscal 2019 to fiscal 2020; net income was positive in 10 of 10 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-09-30, Becton, Dickinson and Co.'s diluted share count grew about 0.1% a year, and dividends and buybacks returned about 48% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 22 sales (20 under scheduled 10b5-1 plans) and 0 purchases of their own stock on the open market in the year to 2026-11-10 (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-09-30, Becton, Dickinson and Co. earned about 7 cents of profit for every dollar of shareholders' money, and gross profitability: its products earned about 18 cents per dollar of everything the company owns (revenue less the cost of revenue). Leverage: it owed about 54 cents per dollar of assets, and net share issuance: its share count shrank 0.9% over the year (the filed statements).

From the record

Becton, Dickinson and Co.'s standing among 109 graded names in its industry family: revenue of $22 billion in fiscal 2025 ranks in the top 3% by size; a net margin of 7.7% ranks in the top 22%; revenue growth of 5% a year over the last 3 filed years ranks in the bottom 33% (its annual reports).

From the record

Becton, Dickinson and Co.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Polen, Thomas E Jr (Chairman, CEO and President, as filed), filing under that title since 2022-08-17, 4.2 years (bottom 45% of its family); the 28 officers and directors filing in the last fifteen months have been on the record a median of 4.2 years (bottom 26%); 13 officer or director changes were reported on Form 8-K since 2023-11-13, against the 28 people in charge now (top 43%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Becton, Dickinson and Co.'s room to grow, from the newest filed statements (fiscal 2025): cash of $641 million against debt of $18 billion leaves -30.7% of its assets as net cash, bottom 7% of its family; cash from operations less capital spending is 12.2% of revenue (top 23%); a gross margin of 45.4% (bottom 26%); research spending of 5.8% of revenue (bottom 26%) (its annual report).

From the record

Becton, Dickinson and Co.'s growth drivers, from the filed years to fiscal 2025: revenue grew 5% a year over the last three filed years against 6.4% over all 10, slowing (bottom 43% of its family); the newest year grew 8.2% (bottom 36%); research spending grew 0.2% a year (bottom 34%); capital spending grew -7.9% a year (bottom 42%) (its annual reports). Becton, Dickinson and Co. reported 3 lines of business in fiscal 2025: Medical at $11 billion, Interventional at $5.2 billion, Life Sciences at $5.2 billion. 2 of 3 grew in the latest filed year, and the largest line is 52% of revenue (its annual report).

From the record

Becton, Dickinson and Co.'s newest year against its own record: revenue of $22 billion in fiscal 2025 came in 4.7% above the $21 billion its prior three years' pace pointed to (top 25% of its family); net income of $1.7 billion against a prior three-year average of $1.7 billion (bottom 39%); a net margin of 7.7% against 8.5% before (bottom 27%) (its annual reports).